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ABSTRACT
Objective To compare the ability of transvaginal sono-
graphy and serum CA 125 levels to predict myometrial
invasion in patients with endometrial carcinoma.
Design and methods Prospective study in 50 consecutive
patients (mean age 60 years, SD 10.5, range 29–77 years)
diagnosed as having endometrial cancer and scheduled for
surgical staging. All patients were evaluated by trans-
vaginal ultrasonography. Endometrial thickness was meas-
ured in all cases and myometrial invasion was estimated as
< 50% or ≥ 50%. Serum CA 125 level was determined in
each patient. A cut-off level of ≥ 35 IU/ml was considered
to predict myometrial invasion of ≥ 50%. All patients
underwent surgical staging, and definitive histopathologi-
cal findings regarding myometrial invasion were used as
the ‘gold standard’. Sensitivity, specificity and positive pre-
dictive value (PPV) and negative predictive value (NPV)
were calculated for transvaginal ultrasonography and CA
125 and compared.
Results On histopathological analysis, myometrial inva-
sion was found to be < 50% in 35 (70%) cases and ≥ 50%
in 15 cases (30%). Mean endometrial thickness in patients
with superficial invasion was significantly lower than in
those with deep invasion (13.4 mm (95% CI 11.2–15.7) vs.
18.7 mm (95% CI 15.0–22.3), respectively; p = 0.014).
Median CA 125 was significantly higher in patients with
deep invasion than in those with superficial invasion
(30 IU/ml, interquartile range (IQR) 46.0 vs. 16.9 IU/ml,
IQR 13.9, respectively; p = 0.002). The sensitivity, specifi-
city, PPV and NPV for transvaginal ultrasonography were
86.7% (95% CI 59.5–98.3), 94.3% (95% CI 80.8–99.3),
86.7% (95% CI 59.5–98.3) and 94.3% (95% CI
80.8–99.3), respectively.  The sensitivity, specificity, PPV
and NPV for CA 125 were 40% (95% CI 16.3–67.7),
91.4% (95% CI 76.9–98.2), 66.7% (95% CI 29.9–92.5)
and 78% (95% CI 63.4–89.5), respectively. The sensitivity
of transvaginal ultrasonography was significantly higher
than that of CA 125 (p = 0.008). No differences were
found in terms of specificity, PPV or NPV.
Conclusion Our results indicate that transvaginal ultra-
sonography is more sensitive than CA 125 in predicting
myometrial invasion in endometrial cancer.
INTRODUCTION
Endometrial carcinoma is the most frequent gynecological
malignancy in women1. Since 1988, the International
Federation of Gynecology and Obstetrics (FIGO) has rec-
ommended surgical staging as the initial treatment in these
patients in order to determine the extent of disease. This
implies total abdominal hysterectomy with bilateral
salpingo-oophorectomy, peritoneal cytological sampling
and pelvic and periaortic lymphadenectomy2. However,
complete routine staging has come under criticism in cases
in which the risk of lymph node involvement is low3,4.
Furthermore, it has been shown that lymphadenectomy can
be safely obviated in selected cases5.
Myometrial invasion is one of the most important
factors associated with lymph node metastases6. Some
authors advocate perioperative gross or frozen-section
evaluation for myometrial infiltration in clinical stage I
endometrial cancer to aid the decision of whether
lymphadenectomy should be performed or not7–9. Frozen-
section evaluation has been shown to be highly accurate in
determining myometrial invasion (94%)10. However, it is
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time consuming and is not performed in all hospitals. Con-
versely, gross evaluation has been shown to be much less
accurate11,12. Therefore, a method that could reliably assess
myometrial invasion preoperatively would be advisable to
provide individual tailoring of the surgical approach.
Abdominal ultrasound has been shown to predict
myometrial infiltration with an acceptable degree of accu-
racy13–15. The introduction of transvaginal ultrasonography
(TVS) has improved this ability further16–18.
CA 125 serum levels in patients with endometrial carci-
noma correlate with the extent of disease19. Several studies
have shown that the higher the preoperative CA 125 levels,
the higher the risk of deep myometrial invasion20–23.
The aim of the present study was to compare the diag-
nostic accuracy of predicting myometrial invasion by TVS
and serum CA 125 levels in the preoperative evaluation of
women with endometrial cancer.
MATERIALS AND METHODS
This was a prospective study designed to assess the diag-
nostic performance of TVS and serum CA 125 levels in
predicting myometrial infiltration in the preoperative
evaluation of a series of consecutive and unselected patients
with endometrial carcinoma scheduled for surgical staging
at our center.
According to the method of Campbell and colleagues24,
it was estimated that a sample size of at least 31 patients
would be required, to detect a difference of at least 20% in
terms of sensitivity, specificity, positive predictive value
(PPV) and negative predictive value (NPV) in a two-sided
test at the 5% significant level with a power of 80%.
Patients were recruited between December 1995 and
March 1999. Fifty women were enrolled in the study. The
patients’ mean age was 60 years (SD 10.5, range 29–77
years). Out of 50, 42 (84%) were postmenopausal. The
mean time elapsed from the menopause in postmenopausal
women was 12.5 years (SD 7.9, range 1–36 years).
All patients were evaluated prior to surgery by trans-
vaginal ultrasonography using a Philips P-700 SE machine
(Philips Ultrasound, Santa Ana, CA, USA) with real-time
6.5-MHz sector electronic phased-array endovaginal
probe. All examinations were performed with the woman
in the lithotomy  position and after she had completely
voided her bladder.
After the endovaginal probe was gently inserted into the
vagina, the uterus and adnexal regions were thoroughly
scanned. The uterus was measured in the three orthogonal
planes. From a sagittal uterine section, endometrial thick-
ness, at the level of maximum thickness, including both
endometrial layers, was measured using on-screen elec-
tronic calipers. Myometrial invasion was suspected when
the myometrial–endometrial interface was ill-defined. The
depth of infiltration was estimated according to the method
of Weber and co-workers25 and stated as < 50% or ≥ 50%
(Figures 1 and 2). Those cases in which no myometrial
invasion was suspected, e.g. where the myometrial–
endometrial interface was well defined, were included in
the group of < 50% for analysis purposes.
All examinations were performed by one examiner
(J.L.A.). Intraobserver variability for endometrial thickness
was estimated by performing two measurements at 10-min
intervals in the first ten patients included, and calculating
the intraclass correlation coefficient26. Intraobserver agree-
ment for ultrasound-estimated myometrial invasion was
assessed by using Cohen’s kappa index (κ). This was done
by performing two different estimations of myometrial in-
vasion in the first ten patients. The intraclass correlation
coefficient for endometrial thickness was 0.97. Agreement
for myometrial invasion (no invasion or < 50% vs. ≥ 50%)
was high (κ = 0.78).
Blood samples were collected for serum CA 125 level
determination on the same day as the ultrasound examina-
tion. An enzyme immunoassay with monoclonal antibody
was used (Cobas-Core CA-125-IITM, Laboratories Roche,
Basel, Switzerland). The sensitivity was < 5 IU/ml. The in-
ter- and intra-assay coefficients of variation were < 7.5%
and < 5.3%, respectively. A cut-off level of ≥ 35 IU/ml was
used for the suspicion of deep myometrial invasion21.
Figure 1 Transvaginal ultrasound scan in a case of a patient with
endometrial cancer showing suspected deep myometrial invasion.
Note the anteroposterior uterine diameter (40 mm) and endo-
metrial thickness (20 mm)
Figure 2 Transvaginal ultrasound scan in a case of a patient with
endometrial cancer showing suspected superficial myometrial in-
vasion. Note the anteroposterior uterine diameter (43 mm) and
endometrial thickness (8.7 mm)
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All patients underwent surgical staging at our center
within 1 week after TVS and CA 125 determination.
Definitive histopathological diagnosis regarding
myometrial infiltration was used as the ‘gold standard’.
Surgical staging was   performed according to FIGO
criteria27.
The Kolmogorov–Smirnov test was used to assess the
normal distribution of continuous variables. Two-tailed
Student’s t test or the Mann–Whitney U test were used to
compare continuous data. Categorical variables were com-
pared using Fisher’s exact test.
Data are presented as mean with 95% confidence inter-
vals (CI) or median with interquartile range, according to
data distribution.
Sensitivity, specificity, positive predictive value (PPV)
and negative predictive value (NPV) were calculated for
TVS and CA 125 and compared using the McNemar test.
Receiver operating characteristic (ROC) analysis was
used to determine whether the pre-established CA 125
cut-off value was the optimal one. ROC analysis was also
used to determine the best endometrial thickness cut-off
value for prediction of deep myometrial invasion. The best
cut-off level was chosen according to the best combination
of sensitivity and false-positive rate.
A p value of less than 0.05 was considered statistically
significant in all tests used. All statistical analyses were
performed with the SPSS 6.1 for Windows (SPSS Inc.,
Chicago, IL, USA) and the Epi-Info (WHO, Geneva,
Switzerland) statistical packages.
RESULTS
Fifty patients with endometrial cancer were included in this
study. In all patients TVS could be satisfactorily performed,
serum CA 125 levels determined and surgical staging done.
Histopathology revealed deep myometrial invasion in
15 patients (30%). In 35 women (70%) no invasion (n = 7)
or < 50% infiltration (n = 28) was found. Surgical stages
were as follows: stage Ia, seven (14%); stage Ib, 22 (44%);
stage Ic, eight (16%); stage IIb, three (6%); stage IIIa, four
(8%); stage IIIc, six (12%). Histology was as follows:
endometrioid adenocarcinoma, 40 (80%); clear-cell carci-
noma, one (2%); papillary carcinoma, two (4%); adeno-
squamous carcinoma, five (10%); sarcoma, two (4%).
Overall mean endometrial thickness was 15 mm (SD
6.9, range 3.4–30 mm). The mean thickness in patients
with deep infiltration was significantly higher than that
with no, or < 50%, invasion (Table 1). The median CA 125
level was 18.2 IU/ml (IQR 17.3, range 3.8–206 IU/ml). The
median CA 125 level in patients with deep invasion was
significantly higher than that with no, or < 50%, invasion
(Table 1).
Deep invasion was suspected on TVS in 15 patients
(30%) and superficial invasion (no, or < 50%) in 35 (70%)
(Table 2). Nine out of 50 (18%) patients had a CA 125
level higher than 35 IU/ml (Table 3).
The sensitivity, specificity, PPV and NPV for TVS and
CA 125 are shown in Table 4. The sensitivity for TVS
was found to be significantly higher than that for CA 125
(p = 0.008). No significant differences were found in terms
of specificity, PPV and NPV.
ROC  analysis showed that the best cut-off level  for
endometrial thickness was 14 mm. However, its diagnostic
performance was quite low (Figure 3). ROC analysis for
CA 125 indicated that the best cut-off level was 30 IU/ml
with a sensitivity of 53.7% and a false-postive rate of 8.6%
(specificity 91.4%) (Figure 3). These values were not statis-
tically different from those for TVS.
Two out of three cases of stage IIb cancer were correctly
diagnosed by transvaginal ultrasound. The CA 125 values
MI < 50% MI ≥ 50%
Mean endometrial thickness (mm)*
Median CA 125 (IU/ml)†
13.4 (95% CI 11.2–15.7)
16.4 (IQR 13.9)
18.7 (95% CI 15.0–22.3)
30.0 (IQR 46.0)
IQR, interquartile range; *ANOVA, p = 0.014; †U test, p = 0.002
Table 1 Endometrial thickness and CA 125 according to histopathological diagnosis of myometrial invasion (MI)
Histopathology
TVS MI < 50% MI ≥ 50%
MI < 50%
MI ≥ 50%
33
2
2
13
Table 2 Transvaginal sonography (TVS) and histopathological
diagnoses of myometrial invasion (MI)
Histopathology
CA 125 MI < 50% MI ≥ 50%
< 35 IU/ml
≥ 35 IU/ml
32
3
9
6
Table 3 CA 125 and histopathological diagnoses of myometrial
invasion (MI)
Sensitivity* Specificity† PP NP
TVS
CA 125
86.7% (59.5–98.3%)
40% (16.3–67.7%)
94.3% (80.8–99.3%)
91.4% (76.9–98.2%)
86.7% (59.5–98.3%)
66.7% (29.9–92.5%)
94.3% (80.8–99.3%)
78.0% (63.4–89.5%)
*p = 0.008; †NS
V† V†
Table 4 Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for transvaginal sonography (TVS)
and CA 125
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of these cases were 41.6 IU/ml, 25 IU/ml and 28.8 IU/ml,
respectively.
DISCUSSION
Surgical staging is currently the recommended initial thera-
peutic approach in patients  with clinical stage I endo-
metrial carcinoma. This surgical stage requires total
abdominal hysterectomy with bilateral salpingo-oophorec-
tomy, peritoneal cytological washings and pelvic and
periaortic lymphadenectomy2.
However, in some selected cases, in which the risk of
lymph node involvement is low, lymphadenectomy may be
unnecessary. The main criterion used to decide this
approach is perioperative  gross or frozen-section evalu-
ation of  myometrial  invasion  at  the time  of surgery7–9.
Frozen sections have been demonstrated to be highly accu-
rate10. Gross evaluation accuracy, however, is limited11,12.
Accurate preoperative assessment of myometrial inva-
sion would be useful in some clinical settings in which
prolonged surgery might be contraindicated, for example
in patients with obesity, cardiovascular disorders or
advanced age. Preoperative assessment would allow the
planning of both surgery and therapy on an individual
basis.
Several imaging techniques have been evaluated to
determine their diagnostic performance in predicting
myometrial invasion in patients with endometrial cancer.
Computerized tomography (CT) has not been shown to be
useful28. Magnetic resonance imaging (MRI) has been
demonstrated to be highly accurate, with sensitivity
ranging from 56 to 91%29–32. TVS has also been found
to be accurate, with sensitivity ranging from 78 to
93%16–18,25,33,34. Some studies have demonstrated that TVS
is as accurate as MRI35,36. Although, to the best of our
knowledge, no cost–benefit analysis comparing both
methods has been reported, we believe that, on the basis of
the costs of each technique, TVS should be performed as
the first step.
CA 125 is a celomic antigen that has been found to
correlate with the extent of disease in endometrial cancer19.
Several studies have demonstrated that high levels are asso-
ciated with deep myometrial invasion20–23. With a cut-off
level of ≥ 35 IU/ml, the sensitivity of detecting deep infiltra-
tion is about 50%20–23.
In our study we have compared the diagnostic perform-
ance of TVS and CA 125 in detecting myometrial invasion
in patients with endometrial cancer. Analyzed separately,
our results regarding TVS are similar to those of previous
studies16–18,25,33,34, showing a high sensitivity and specificity.
We had two cases of overestimation of myometrial inva-
sion. These two cases were one stage Ia and one stage Ib in
which the carcinoma arose from a large endometrial polyp.
This could explain the mistake in estimation. We also had
two cases of underestimation of myometrial invasion. In
these cases endometrial thickness was 6.0 mm and 8.1 mm,
respectively.
With respect to CA 125, our results are similar to those
of previous studies20–23, resulting in high specificity but low
sensitivity.
When comparing both methods, the sensitivity of TVS
was significantly higher than that for CA 125. The only
previous study that compared ultrasound with CA 125 in
predicting myometrial invasion was reported by Lehtovirta
and co-workers37. They found that the prediction of ultra-
sound was superior to that of CA 125 levels. Our results
confirm and support these previous results. However, if we
use the best CA 125 cut-off level found on ROC analysis
(30 IU/ml), there is no difference between the   two
methods. This finding regarding the optimal CA 125 cut-
off level is in agreement with the results of a recent study
reported by Kurihara and colleagues, who found that
the best cut-off level for preoperatively predicting deep
myometrial invasion in a series of 110 postmenopausal
women with endometrial cancer was lower than
35 IU/ml38.
In conclusion, our results indicate that TVS is accurate
in detecting deep myometrial invasion in endometrial
cancer and that it is more sensitive than CA 125 when a
cut-off level of ≥ 35 IU/ml is used. Our findings suggest
that this cut-off value may need to be modified.
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